150 related articles for article (PubMed ID: 10455285)
41. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y
Gündüz D; Tanislav C; Sedding D; Parahuleva M; Santoso S; Troidl C; Hamm CW; Aslam M
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146050
[TBL] [Abstract][Full Text] [Related]
42. ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq.
Ohlmann P; Eckly A; Freund M; Cazenave JP; Offermanns S; Gachet C
Blood; 2000 Sep; 96(6):2134-9. PubMed ID: 10979958
[TBL] [Abstract][Full Text] [Related]
43. Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of arachidonic acid in human platelets.
Dragan YP; Ellis EF
Biochem Pharmacol; 1990 Jan; 39(1):27-32. PubMed ID: 2105095
[TBL] [Abstract][Full Text] [Related]
44. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
Harrison MJ; Brossmer R
Thromb Haemost; 1976 Nov; 36(2):388-91. PubMed ID: 1036839
[TBL] [Abstract][Full Text] [Related]
46. P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig.
Piper AS; Hollingsworth M
Br J Pharmacol; 1996 Apr; 117(8):1721-9. PubMed ID: 8732282
[TBL] [Abstract][Full Text] [Related]
47. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
Simon J; Vigne P; Eklund KM; Michel AD; Carruthers AM; Humphrey PP; Frelin C; Barnard EA
Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
[TBL] [Abstract][Full Text] [Related]
48. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
Mateos-Trigos G; Evans RJ; Heath MF
Platelets; 2002; 13(5-6):285-92. PubMed ID: 12189014
[TBL] [Abstract][Full Text] [Related]
49. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
Egan CM; Fisher AP; Scrutton MC
Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
[TBL] [Abstract][Full Text] [Related]
50. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.
Hechler B; Vigne P; Léon C; Breittmayer JP; Gachet C; Frelin C
Mol Pharmacol; 1998 Apr; 53(4):727-33. PubMed ID: 9547364
[TBL] [Abstract][Full Text] [Related]
51. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
Holmsen H; Setkowsky CA; Day HJ
Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
[TBL] [Abstract][Full Text] [Related]
52. [(35)S]GTPgammaS autoradiography reveals a wide distribution of G(i/o)-linked ADP receptors in the nervous system: close similarities with the platelet P2Y(ADP) receptor.
Laitinen JT; Uri A; Raidaru G; Miettinen R
J Neurochem; 2001 Apr; 77(2):505-18. PubMed ID: 11299313
[TBL] [Abstract][Full Text] [Related]
53. The effect of chromatographically pure sample of adenosine 5'-tetraphosphate on sheep and rabbit blood platelets.
Penglis F
Clin Exp Pharmacol Physiol; 1977; 4(2):173-82. PubMed ID: 884907
[TBL] [Abstract][Full Text] [Related]
54. Multiple P2Y receptors mediate contraction in guinea pig mesenteric vein.
Mutafova-Yambolieva VN; Carolan BM; Harden TK; Keef KD
Gen Pharmacol; 2000 Feb; 34(2):127-36. PubMed ID: 10974420
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
Baurand A; Raboisson P; Freund M; Léon C; Cazenave JP; Bourguignon JJ; Gachet C
Eur J Pharmacol; 2001 Feb; 412(3):213-21. PubMed ID: 11166284
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of ADP-induced aggregation of human platelets by beta, gamma-methylene-ATP.
Evans PM
Cytobios; 1978; 23(90):101-8. PubMed ID: 158489
[TBL] [Abstract][Full Text] [Related]
57. Nucleotide-evoked relaxation of rat vas deferens--a possible role for endogenous ATP released upon alpha(1)-adrenoceptor stimulation.
Bültmann R; Starke K
Eur J Pharmacol; 2001 Jun; 422(1-3):197-202. PubMed ID: 11430931
[TBL] [Abstract][Full Text] [Related]
58. Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor.
Cattaneo M; Lecchi A; Ohno M; Joshi BV; Besada P; Tchilibon S; Lombardi R; Bischofberger N; Harden TK; Jacobson KA
Biochem Pharmacol; 2004 Nov; 68(10):1995-2002. PubMed ID: 15476670
[TBL] [Abstract][Full Text] [Related]
59. Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Feb; 75(2):397-400. PubMed ID: 7186826
[TBL] [Abstract][Full Text] [Related]
60. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
